Our Mission
Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness
— Latest Updates
News
CIMAR Outreach Day Provides High Schoolers Rare Educational and Networking Opportunities
The Tufts Center for Integrated Management of Antimicrobial Resistance hosted 33 students from Boston-area Brockton High School last week for a science outreach event. The students presented posters depicting original experiments and data on antimicrobial resistance to a wide audience of Tufts University and Tufts Medical Center graduate students, postdoctoral fellows, faculty, and clinicians.
Tufts Researchers Find Link Between Dog-Human Antibiotic Resistance
For many people, pets are family; just as close to them as the humans in their life. However, a new study suggests that closeness can create a concerning health issue making prescribed medicines less effective. …
IDSA announces Tufts Medical Center Among Recipients of Antimicrobial Stewardship Centers of Excellence Designation
The Infectious Diseases Society of America (IDSA) announced today the recipients of its Antimicrobial Stewardship Centers of Excellence (CoE) designation. …
Events
Drug-Resistant Superbugs: CIMAR Symposium Examines the Intersection of People, Animals, Food, and the Environment, and Their Impact on Health
April 9, 2019
The Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR) held its first symposium in Boston on March 18th. The event brought together over 175 clinicians and researchers from academia, medicine, and industry, all interested in fighting drug-resistant diseases via a “One Health” approach. One Health prioritizes the relationship among people, animals, the environment, and the foods we all consume as critical avenues by which drug-resistant bacteria spread from one to another
Metabolic Modeling Predicts Unique Drug Targets in Lyme Disease Pathogen B. burgdorferi – TUSM’s Peter Gwynne, PhD
February 23, 2023
We were pleased to hear from Bryan Lenneman, Ph.D., today on “Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens.” Dr. Lenneman is a Research Fellow at Massachusetts General Hospital whose research interests include utilizing synthetic biology to develop novel therapeutics against diseases associated with dysbiosis of the human gut microbial community.
Superbugs From Their Backyards and Beyond: Brockton High Schoolers Present “Tiny Earth” Findings to Levy CIMAR; Tufts Community
January 13, 2026
CIMAR hosted 33 students from Boston-area Brockton High School last week for a rare educational and networking opportunity. Students presented posters depicting original experiments and data on antimicrobial resistance to a wide audience of Tufts University and Tufts Medical Center members.
Our Trainees
Ashley Luo
Ashley Luo, Second-Year Molecular Microbiology (MERGE-ID Track) PhD Candidate
Maryam Utegulova
Maryam Utegulova, 2025 Recipient of the Levy CIMAR Undergraduate Summer Internship in Science and Medicine
Mallika Subramanian
Mallika Subramanian, 2025 Recipient of the Levy CIMAR Undergraduate Summer Internship in Science and Medicine
Publications
CIMAR on Bluesky
Follow us on
Our Values
The Levy CIMAR is committed to a culture of diversity, equity, and inclusion both within our organization and for all people who are impacted by our work. We strive for health equity for people from all backgrounds and identities, and we actively support societal and institutional structures that promote justice and equality. We are also committed to being a safe, respectful, and inclusive environment for our trainees, staff, faculty, affiliates, and partners. One Health acknowledges the interconnectedness of allhumans, along with animals and our environments. Antimicrobial resistance impacts us all.